Skip to content

He-move-philia, Lifestyle Intervention for Patients With Hemophilia

He-move-philia, a Combined Lifestyle Intervention Program for Patients With Hemophilia and Other Bleeding Disorders

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05608863
Enrollment
30
Registered
2022-11-08
Start date
2022-11-02
Completion date
2026-12-31
Last updated
2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia

Brief summary

The main objectives are reduction of body weight, BMI and abdominal circumference. Secondary objectives are reduction of bleeds and units coagulation factor concentrate used, blood-pressure, cholesterol spectrum, glucose and improvement of physical activity and dietary habits. one group of patients will receive a combined lifestyle intervention program with individual sessions and group sessions lasting for 2 years, the other group of patients will receive individual sessions only and will be given the same information as given in the group sessions, but on paper.

Detailed description

The prevalence of overweight and obesity is increasing in patients with hemophilia and other bleeding disorders. In these patients physical activity is often difficult due to arthropathy as a result of intra-articular bleeding in the past, with decreased joint movement and pain and the fear of new bleeds. This enhances weight gain, increases pressure on joints, leading to more bleeds and more arthropathy. In the long term overweight and obesity increases risk of cardiovascular diseases, with the concomitant need for anticoagulant therapy, which further enhances the bleeding risk in these patients. The aim of this exploratory study is to compare the effect of a lifestyle intervention program consisting of combined individual coaching and group sessions (CLI) with a lifestyle intervention program with individual coaching only (II).The program is especially designed for patients with a bleeding disorder. The investigators hypothesize that body weight, BMI, abdominal circumference, bleeds and units coagulation factor concentrate, as these are dosed on body weight, will decrease in both groups, but more in the CLI with group sessions.

Interventions

OTHERLifestyle - group sessions

The Combined Lifestyle Intervention Program consists of a total of 7 individual coaching sessions and 16 group sessions in a 2 year program. The individual coaching sessions will be done in a virtual setting.

OTHERLifestyle - individual coaching

The Individual Intervention consists of a total of 7 individual coaching sessions in a 2 year program and additional written information. These will be done in a virtual setting.

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with hemophilia A, B, FVII deficiency, fibrinogen deficiency, von Willebrand Disease or other bleeding disorder preferably requiring coagulation products for prophylaxis or on demand in case of bleeding * ≥ 18 years of age * BMI ≥ 30 kg/m2 * Motivated to change their lifestyle * Being able to speak, read and understand the Dutch language

Exclusion criteria

* Health care insurance with CZ or ONVZ as these health insurances have no contract with Profitt Lifestylecoaching. * A contraindication or inability for physical activity as judged by the treating hemophilia physician * Participation in another research trial * Unable to understand the written information * Unable to sign the informed consent * Unwilling to randomize to the combined or individual intervention group

Design outcomes

Primary

MeasureTime frameDescription
kg36 monthsThe main study parameter is body weight in kg.

Secondary

MeasureTime frameDescription
Number of induced bleeds36 months
Units coagulation factor concentrate used/year (IU)36 months
Blood-pressurre (mm Hg)36 months
Number of spontaneous bleeds36 months
Haemophilia activities of daily life (HAL)36 monthsTotal score
Shortened Fat List36 monthsTotal score
Abdominal circumference (cm)36 months
Cholesterol spectrum36 monthsincluding: total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol (mmol/l), all in non-fasting state
Glucose (mmol/l)36 monthsin non-fasting state

Other

MeasureTime frame
Regulation of Eating Behaviour Scale (REBS)Baseline (week 0)
Patient satisfaction with the program will be measured using some questions36 months
BREQ-3 questionnaireBaseline (week 0)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026